According to the Vietnam News Agency correspondent in Latin America, on February 13, Peruvian President Francisco Sagasti approved the resignation application of Health Minister Pilar Mazzetti, after the incident. scandal involving former President Martin Vizcarra’s admission of receiving an experimental COVID-19 vaccine during his time in office.
The head of the Peruvian health agency resignation takes place in the context that this South American country has just started to conduct the vaccination program COVID-19 with the vaccine of the pharmaceutical company Sinopharm (China).
In an interview with RPP radio station, President Sagasti said Mazzetti had submitted her resignation a day earlier and said she had suffered “unfair” treatment from the National Assembly despite her many years of tribute. donated to the national health sector. According to Mr. Sagasti, the new head of the Ministry of Health will be Dr. Oscar Ugarte, who held the position 10 years ago.
[Peru chi 26 triệu USD mua vắcxin ngừa COVID-19 của Trung Quốc]
On February 11, former President Vizcarra said he volunteered to participate in the Sinopharm vaccine trial in October 2020, a month before he was deposed by Congress on allegations of corruption. Immediately after Vizcarra’s revelation, Mazzetti was summoned to Congress to give an explanation and said she did not know if the former Peruvian president would participate in the vaccine trials carried out late last year.
Opposition MPs in Congress then asked Mazzetti to leave the leadership of the country’s health sector and became the fifth health minister to step down since the outbreak of the COVID-19 pandemic. in South America.
Since February 9, Peru has started giving the COVID-19 vaccine to health workers exposed to the epidemic, in a time when the country was facing a second wave of epidemics with a system. Medical is always in a state of overload.
Currently, the South American country with 33 million people has negotiated with many pharmaceutical companies in the world to buy COVID-19 vaccines such as Sinopharm (38 million doses), Pfizer (20 million doses), AstraZeneca (14 million doses) and mechanism United Nations vaccine distribution COVAX (13.2 million doses). In addition, the government also sought other sources from Johnson & Johnson, Moderna, Novavax, Gamaleya, Sinovac and Curevac./.